Guido G Kobbe


Ontology type: schema:Person     


Person Info

NAME

Guido G

SURNAME

Kobbe

Publications in SciGraph latest 50 shown

  • 2022-08-03 B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma — a case report in ANNALS OF HEMATOLOGY
  • 2022-07-23 Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT in BONE MARROW TRANSPLANTATION
  • 2022-03-24 Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT in BONE MARROW TRANSPLANTATION
  • 2022-03-09 Therapy-related myeloid neoplasms following treatment for multiple myeloma—a single center analysis in ANNALS OF HEMATOLOGY
  • 2022-01-04 First-line high-dose therapy and autologous blood stem cell transplantation in patients with primary central nervous system non-Hodgkin lymphomas—a single-centre experience in 61 patients in ANNALS OF HEMATOLOGY
  • 2021-10-04 Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia in BLOOD CANCER JOURNAL
  • 2021-06-23 Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2021-02-02 Erratum zu: Diagnostik und Therapie der chronischen myelomonozytären Leukämie im Jahr 2020 in BEST PRACTICE ONKOLOGIE
  • 2021-01-08 Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2021-01-04 Diagnostik und Therapie der chronischen myelomonozytären Leukämie im Jahr 2020 in BEST PRACTICE ONKOLOGIE
  • 2020-11-16 Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2020-11-07 Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes in ANNALS OF HEMATOLOGY
  • 2020-09-02 Wilm’s Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2020-07-24 Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT in BONE MARROW TRANSPLANTATION
  • 2020-07-07 Erratum zu: Impfen bei Immundefizienz in BUNDESGESUNDHEITSBLATT - GESUNDHEITSFORSCHUNG - GESUNDHEITSSCHUTZ
  • 2020-04-29 Impfen bei Immundefizienz in BUNDESGESUNDHEITSBLATT - GESUNDHEITSFORSCHUNG - GESUNDHEITSSCHUTZ
  • 2019-11-12 Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS in BLOOD CANCER JOURNAL
  • 2019-11-11 EASIX for prediction of survival in lower-risk myelodysplastic syndromes in BLOOD CANCER JOURNAL
  • 2019-09-18 Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor in BONE MARROW TRANSPLANTATION
  • 2019-09-03 Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-03-29 Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies in ANNALS OF HEMATOLOGY
  • 2018-12-20 Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia in LEUKEMIA
  • 2018-08-04 Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy in ANNALS OF HEMATOLOGY
  • 2018-02-12 Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells in NATURE MEDICINE
  • 2017-11-18 Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group in ANNALS OF HEMATOLOGY
  • 2017-11-15 Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantation in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-06-13 Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation in ANNALS OF HEMATOLOGY
  • 2017-05-04 A retrospective study evaluating the impact of infectious complications during azacitidine treatment in ANNALS OF HEMATOLOGY
  • 2017-01-18 Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia in LEUKEMIA
  • 2017-01-16 Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT in LEUKEMIA
  • 2016-02-08 Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas in BONE MARROW TRANSPLANTATION
  • 2015-11-25 Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia in LEUKEMIA
  • 2015-11-16 Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT in BONE MARROW TRANSPLANTATION
  • 2015-10-17 Somatische Mutationen als mögliche prognostische oder prädiktive Marker in INFO HÄMATOLOGIE + ONKOLOGIE
  • 2015-09-14 Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL) in BONE MARROW TRANSPLANTATION
  • 2015-08-03 Reply to ‘Allogeneic hematopoietic cell transplantation for concurrent multiple myeloma and myelodysplastic syndrome’ in BONE MARROW TRANSPLANTATION
  • 2015-07-31 Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey in LEUKEMIA
  • 2015-02-24 Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q in LEUKEMIA
  • 2015-01-26 Treatment of donor-specific antibody-mediated graft rejection by immunochemotherapy, third-party DLI, plasmapheresis and immunoadsorption in BONE MARROW TRANSPLANTATION
  • 2014-05-21 Low frequency of calreticulin mutations in MDS patients in LEUKEMIA
  • 2014-02-07 Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation in LEUKEMIA
  • 2013-05-07 SETBP1 mutation analysis in 944 patients with MDS and AML in LEUKEMIA
  • 2013-03-29 Insufficient stromal support in MDS results from molecular and functional deficits of mesenchymal stromal cells in LEUKEMIA
  • 2013-03-01 Salvage therapy with azacitidine increases regulatory T cells in peripheral blood of patients with AML or MDS and early relapse after allogeneic blood stem cell transplantation in LEUKEMIA
  • 2013-01-14 Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation in LEUKEMIA
  • 2012-08-26 The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation in IMMUNOGENETICS
  • 2011-12-20 Blood Stem Cell Mobilization in Solid Tumors: Experience with Plerixafor and Alternative Ways of Hematopoietic Stem Cell Mobilization in NOVEL DEVELOPMENTS IN STEM CELL MOBILIZATION
  • 2011-03-19 High-Dose Therapy and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma in MULTIPLE MYELOMA
  • 2010-07-26 Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases in BONE MARROW TRANSPLANTATION
  • 2010-06-14 The Mexican Way: a feasible approach to avoid DMSO toxicity in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.14778.3d", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411251.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419838.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.467675.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411937.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239395.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419842.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419248.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412354.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413731.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412460.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7468.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239826.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.38142.3c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411095.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.459389.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411730.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6530.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.6936.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7548.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.499820.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410712.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413328.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413396.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48769.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5949.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.24704.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15485.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413662.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410706.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.451052.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.15090.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414818.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.39382.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411984.1", 
            "type": "Organization"
          }
        ], 
        "familyName": "Kobbe", 
        "givenName": "Guido G", 
        "id": "sg:person.01164073234.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-09-02T16:34", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/person/person_707.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01164073234.53'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01164073234.53'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01164073234.53'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01164073234.53'


     

    This table displays all metadata directly associated to this object as RDF triples.

    98 TRIPLES      10 PREDICATES      52 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01164073234.53 schema:affiliation N8cda33880aa540e98ec97eb869f5df1c
    2 grid-institutes:grid.10417.33
    3 grid-institutes:grid.15090.3d
    4 grid-institutes:grid.15485.3d
    5 grid-institutes:grid.239395.7
    6 grid-institutes:grid.239826.4
    7 grid-institutes:grid.24704.35
    8 grid-institutes:grid.38142.3c
    9 grid-institutes:grid.39382.33
    10 grid-institutes:grid.410706.4
    11 grid-institutes:grid.410712.1
    12 grid-institutes:grid.411095.8
    13 grid-institutes:grid.411251.2
    14 grid-institutes:grid.411327.2
    15 grid-institutes:grid.411730.0
    16 grid-institutes:grid.411937.9
    17 grid-institutes:grid.411984.1
    18 grid-institutes:grid.412354.5
    19 grid-institutes:grid.412460.5
    20 grid-institutes:grid.412468.d
    21 grid-institutes:grid.413328.f
    22 grid-institutes:grid.413396.a
    23 grid-institutes:grid.413662.4
    24 grid-institutes:grid.413731.3
    25 grid-institutes:grid.414818.0
    26 grid-institutes:grid.419248.2
    27 grid-institutes:grid.419838.f
    28 grid-institutes:grid.419842.2
    29 grid-institutes:grid.451052.7
    30 grid-institutes:grid.459389.a
    31 grid-institutes:grid.467675.1
    32 grid-institutes:grid.48769.34
    33 grid-institutes:grid.499820.e
    34 grid-institutes:grid.5802.f
    35 grid-institutes:grid.5949.1
    36 grid-institutes:grid.5963.9
    37 grid-institutes:grid.6530.0
    38 grid-institutes:grid.6936.a
    39 grid-institutes:grid.7445.2
    40 grid-institutes:grid.7468.d
    41 grid-institutes:grid.7497.d
    42 grid-institutes:grid.7548.e
    43 schema:familyName Kobbe
    44 schema:givenName Guido G
    45 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01164073234.53
    46 schema:sdDatePublished 2022-09-02T16:34
    47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    48 schema:sdPublisher Nfaae016127a84dbca88d44579b27b3a3
    49 sgo:license sg:explorer/license/
    50 sgo:sdDataset persons
    51 rdf:type schema:Person
    52 N8cda33880aa540e98ec97eb869f5df1c schema:affiliation grid-institutes:grid.14778.3d
    53 sgo:isCurrent true
    54 rdf:type schema:OrganizationRole
    55 Nfaae016127a84dbca88d44579b27b3a3 schema:name Springer Nature - SN SciGraph project
    56 rdf:type schema:Organization
    57 grid-institutes:grid.10417.33 schema:Organization
    58 grid-institutes:grid.14778.3d schema:Organization
    59 grid-institutes:grid.15090.3d schema:Organization
    60 grid-institutes:grid.15485.3d schema:Organization
    61 grid-institutes:grid.239395.7 schema:Organization
    62 grid-institutes:grid.239826.4 schema:Organization
    63 grid-institutes:grid.24704.35 schema:Organization
    64 grid-institutes:grid.38142.3c schema:Organization
    65 grid-institutes:grid.39382.33 schema:Organization
    66 grid-institutes:grid.410706.4 schema:Organization
    67 grid-institutes:grid.410712.1 schema:Organization
    68 grid-institutes:grid.411095.8 schema:Organization
    69 grid-institutes:grid.411251.2 schema:Organization
    70 grid-institutes:grid.411327.2 schema:Organization
    71 grid-institutes:grid.411730.0 schema:Organization
    72 grid-institutes:grid.411937.9 schema:Organization
    73 grid-institutes:grid.411984.1 schema:Organization
    74 grid-institutes:grid.412354.5 schema:Organization
    75 grid-institutes:grid.412460.5 schema:Organization
    76 grid-institutes:grid.412468.d schema:Organization
    77 grid-institutes:grid.413328.f schema:Organization
    78 grid-institutes:grid.413396.a schema:Organization
    79 grid-institutes:grid.413662.4 schema:Organization
    80 grid-institutes:grid.413731.3 schema:Organization
    81 grid-institutes:grid.414818.0 schema:Organization
    82 grid-institutes:grid.419248.2 schema:Organization
    83 grid-institutes:grid.419838.f schema:Organization
    84 grid-institutes:grid.419842.2 schema:Organization
    85 grid-institutes:grid.451052.7 schema:Organization
    86 grid-institutes:grid.459389.a schema:Organization
    87 grid-institutes:grid.467675.1 schema:Organization
    88 grid-institutes:grid.48769.34 schema:Organization
    89 grid-institutes:grid.499820.e schema:Organization
    90 grid-institutes:grid.5802.f schema:Organization
    91 grid-institutes:grid.5949.1 schema:Organization
    92 grid-institutes:grid.5963.9 schema:Organization
    93 grid-institutes:grid.6530.0 schema:Organization
    94 grid-institutes:grid.6936.a schema:Organization
    95 grid-institutes:grid.7445.2 schema:Organization
    96 grid-institutes:grid.7468.d schema:Organization
    97 grid-institutes:grid.7497.d schema:Organization
    98 grid-institutes:grid.7548.e schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...